This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Renal Cancer
Recent Abstracts
Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma - Abstract
May 7, 2014
Immunologics and chemotherapeutics for renal cell carcinoma - Abstract
May 7, 2014
Imaging management of incidentally detected small renal masses - Abstract
May 7, 2014
A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma - Abstract
May 5, 2014
Role of radiation therapy for renal tumors - Abstract
May 5, 2014
Epidemiology and staging of renal cell carcinoma - Abstract
May 5, 2014
Rechallenge of everolimus for metastatic renal cell carcinoma after recovery from grade 3 interstitial lung disease: A case report - Abstract
May 5, 2014
Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: Analysis from the randomized phase III AXIS trial - Abstract
May 3, 2014
Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification - Abstract
May 3, 2014
Controversies in renal cell carcinoma: Treatment choice after progression on vascular endothelial growth factor-targeted therapy - Abstract
May 3, 2014
Balancing cardiovascular and cancer death among patients with small renal mass: Modification by cardiovascular risk - Abstract
May 2, 2014
Cytoreductive nephrectomy for metastatic renal cell carcinoma: A review of the historical literature and its role in the era of targeted molecular therapy - Abstract
May 2, 2014
Port site metastasis after surgery for renal cell carcinoma: Harbinger of future metastasis - Abstract
May 2, 2014
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada - Abstract
May 1, 2014
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy - Abstract
May 1, 2014
Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy - Abstract
May 1, 2014
Association of type of renal surgery and access to robotic technology for kidney cancer: Results from a population-based cohort - Abstract
April 30, 2014
Renal adverse effects of sunitinib and its clinical significance: A single-center experience in Korea - Abstract
April 30, 2014
Efficacy of pre-surgical axitinib for shrinkage of inferior vena cava thrombus in a patient with advanced renal cell carcinoma - Abstract
April 30, 2014
Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma - Abstract
April 29, 2014
Page 349 of 456
Start
Prev
344
345
346
347
348
349
350
351
352
353
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free